A detailed history of Arizona State Retirement System transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 27,359 shares of ITCI stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,359
Previous 24,412 12.07%
Holding current value
$2.27 Million
Previous $1.67 Million 19.69%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.99 - $80.84 $200,366 - $238,235
2,947 Added 12.07%
27,359 $2 Million
Q2 2024

Aug 05, 2024

BUY
$64.76 - $79.84 $39,374 - $48,542
608 Added 2.55%
24,412 $1.67 Million
Q1 2024

May 07, 2024

SELL
$64.37 - $75.65 $23,945 - $28,141
-372 Reduced 1.54%
23,804 $1.65 Million
Q4 2023

Jan 24, 2024

SELL
$46.37 - $73.65 $18,779 - $29,828
-405 Reduced 1.65%
24,176 $1.73 Million
Q3 2023

Nov 06, 2023

BUY
$52.09 - $64.1 $25,784 - $31,729
495 Added 2.06%
24,581 $1.28 Million
Q2 2023

Aug 01, 2023

SELL
$54.67 - $66.44 $33,403 - $40,594
-611 Reduced 2.47%
24,086 $1.53 Million
Q1 2023

Apr 27, 2023

BUY
$43.8 - $56.99 $31,667 - $41,203
723 Added 3.02%
24,697 $1.34 Million
Q4 2022

Feb 07, 2023

BUY
$44.07 - $54.45 $39,883 - $49,277
905 Added 3.92%
23,974 $1.27 Million
Q3 2022

Nov 07, 2022

BUY
$42.7 - $59.99 $23,485 - $32,994
550 Added 2.44%
23,069 $1.07 Million
Q2 2022

Jul 28, 2022

BUY
$43.0 - $65.64 $16,469 - $25,140
383 Added 1.73%
22,519 $1.29 Million
Q1 2022

May 04, 2022

BUY
$38.74 - $62.09 $136,635 - $218,991
3,527 Added 18.95%
22,136 $1.36 Million
Q4 2021

Feb 04, 2022

SELL
$35.2 - $53.42 $6,758 - $10,256
-192 Reduced 1.02%
18,609 $974,000
Q3 2021

Nov 12, 2021

BUY
$28.72 - $42.49 $3,015 - $4,461
105 Added 0.56%
18,801 $701,000
Q2 2021

Aug 02, 2021

SELL
$29.3 - $44.5 $67,536 - $102,572
-2,305 Reduced 10.98%
18,696 $763,000
Q1 2021

May 06, 2021

BUY
$30.8 - $39.51 $11,981 - $15,369
389 Added 1.89%
21,001 $713,000
Q4 2020

Jan 28, 2021

BUY
$23.34 - $32.22 $59,913 - $82,708
2,567 Added 14.23%
20,612 $655,000
Q3 2020

Nov 05, 2020

BUY
$17.61 - $31.86 $79,174 - $143,242
4,496 Added 33.18%
18,045 $463,000
Q2 2020

Aug 04, 2020

SELL
$14.35 - $26.64 $3,444 - $6,393
-240 Reduced 1.74%
13,549 $348,000
Q1 2020

May 05, 2020

BUY
$12.31 - $33.12 $169,742 - $456,691
13,789 New
13,789 $212,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.